Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Liang

Showing results (11-20 of 270) with videos related to

Pageof 27
Sort By:
ACS Medicinal Chemistry Letters|July 16, 2025
Novel (1<i>H</i>‑Pyrazol-4-ylamino)pyrimidine Derivatives as Wee1 Inhibitors for Treatment of CancerSteven H Liang
ACS Medicinal Chemistry Letters|February 19, 2025
Imaging Alpha-synuclein with Novel 5<i>H</i>-Imidazo[1,5-<i>b</i>][1,2,4]triazole Radioligands for the Diagnosis of Parkinson's DiseaseZhendong Song, Steven H Liang
ACS Medicinal Chemistry Letters|March 18, 2026
Synthesis of Novel STING Antagonists and Their Uses in Treatment of STING Related DiseasesHaofeng Shi, Steven H Liang
ACS Medicinal Chemistry Letters|February 18, 2026
Discovery of Quinazolinone Derivatives as Potent PARP1 InhibitorsXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|February 18, 2026
Novel Werner Syndrome RecQ DNA Helicase (WRN) Inhibitors for Cancer TreatmentXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|August 20, 2025
Novel Thieno[3,2‑<i>b</i>]Pyridine Derivatives in the Treatment of Huntington's DiseaseTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Heterocyclic Pyrimidine Derivatives as GSK3α InhibitorsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Azaindole Compounds as Phosphodiesterase 4B Inhibitors for Treating Immune-Inflammatory Diseases or DisordersZhendong Song, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Tricyclic Compounds as GSK3 InhibitorsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
Novel 6-Aryl isoindolin-1-one Derivatives as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 2Yinlong Li, Steven H Liang
Pageof 27

Showing results (11-20 of 270) with videos related to

Sort By:
Pageof 27
ACS Medicinal Chemistry Letters|July 16, 2025
Novel (1<i>H</i>‑Pyrazol-4-ylamino)pyrimidine Derivatives as Wee1 Inhibitors for Treatment of CancerSteven H Liang
ACS Medicinal Chemistry Letters|February 19, 2025
Imaging Alpha-synuclein with Novel 5<i>H</i>-Imidazo[1,5-<i>b</i>][1,2,4]triazole Radioligands for the Diagnosis of Parkinson's DiseaseZhendong Song, Steven H Liang
ACS Medicinal Chemistry Letters|March 18, 2026
Synthesis of Novel STING Antagonists and Their Uses in Treatment of STING Related DiseasesHaofeng Shi, Steven H Liang
ACS Medicinal Chemistry Letters|February 18, 2026
Discovery of Quinazolinone Derivatives as Potent PARP1 InhibitorsXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|February 18, 2026
Novel Werner Syndrome RecQ DNA Helicase (WRN) Inhibitors for Cancer TreatmentXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|August 20, 2025
Novel Thieno[3,2‑<i>b</i>]Pyridine Derivatives in the Treatment of Huntington's DiseaseTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Heterocyclic Pyrimidine Derivatives as GSK3α InhibitorsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Azaindole Compounds as Phosphodiesterase 4B Inhibitors for Treating Immune-Inflammatory Diseases or DisordersZhendong Song, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Tricyclic Compounds as GSK3 InhibitorsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
Novel 6-Aryl isoindolin-1-one Derivatives as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 2Yinlong Li, Steven H Liang
Pageof 27